News

2015 Psychiatry Annual Meetings

2015 168th Annual Meeting of the American Psychiatric Association
May 16-20, 2015

Saturday, May 16

TimeLocationPresenterSession Title3:30 p.m.Room 204

Harold Kudler, MD

From Riches to Rags: The Veteran and the Public Mental Health System

 

Sunday, May 17

TimeLocationPresenterSession Title1:00 p.m.Room 718 A

Dan Blazer, MD, MPH, PhD

Older Patients Telling Stories to Doctors in a Technological Age

 

Monday, May 18

TimeLocationPresenterSession Title8:00 a.m.Mezzanine, Chestnut East-West

Andrew Krystal, MD, MS

ECT Practice Update for General Psychiatrist11:00 a.m.Room 104 B

Marvin Swartz, MD

Psychiatry in the Courts: APA Confronts Legal Issues of Concern to the Field

 

Tuesday, May 19

TimeLocationPresenterSession Title9:00 a.m.Rooms 201 A-F

Sarah Lisanby, MD

Seizure Therapy for Depression: Teaching an ‘Old Dog’ Some ‘New Tricks’

Mustafa Husain, MD

Safety and Efficacy of Right Unilateral Ultra-Brief Pulse Electroconvulsive Therapy in Depressed Seniors: New Insights From the Prolonging Remission in Depressed Elders Trial

Angel Peterchev, PhD

Dose for Seizure Therapy: Definitions and Implications for Practice

1:30 p.m.Room 713 A-B

Rachel Dew, MD, MHSc

Mediation and Moderation of Religion Substance Abuse Relationships by Genotype2:00 p.m.Exhibit Hall D-E

Richard Keefe, PhD

Effect of Vortioxetine on Functionality Capacity in Patients with Major Depressive Disorder Subjectively Reporting Cognitive Dysfunction

 

Wednesday, May 20

TimeLocationPresenterSession Title2:00 p.m.Room 718 A

Warren Kinghorn, MD

“When sorrows like sea billows roll”: Depression in Evangelical and Fundamentalist Christian Communities3:30 p.m.Rooms 202 C-D

Jeffrey Swanson, PhD

Do Firearms Restrictions Prevent Suicide and Violence in People With Serious Mental Illness?

Posters

#TitlePresenter0231Geriatric Psychiatry: Treatment Updates and New Perspectives

Dan Blazer, MD, MPH, PhD

0251Faith and Major Depressive Disorder: DSM-5, the Cultural Formulation Interview and Tradition-Based Responses

Warren Kinghorn, MD

0325From Riches to Rags: The Veteran and the Public Mental Health System

Harold Kudler, MD

0747Nowhere to Go: The Crisis of Psychiatric Patients Boarding in Emergency DepartmentsMarvin Swartz, MD0771Mediation and Moderation of Religion Substance Abuse Relationships by Genotype

Rachel Dew, MD, MHSc

0825Do Firearms Restrictions Prevent Suicide and Violence in People With Serious Mental Illness?

Jeffrey Swanson, PhD

2338ECT Practice Update for the General Psychiatrist

Andrew Krystal, MD, MS

2806Seizure Therapy for Depression: Teaching an ‘Old Dog’ Some ‘New Tricks”

Sarah Lisanby, MD, Mustafa Husain, MD

3324

Post Hoc Analyses of Anxiety Measures in Adult Patients with Generalized Anxiety Disorder Treated with Vilazodone

Arif Khan, MDP8-047Effect of Vortioxetine on Functionality Capacity in Patients with Major Depressive Disorder Subjectively Reporting Cognitive Dysfunction

Richard Keefe, PhD

Society of Biological Psychiatry 70th Annual Scientific Meeting
Stress, Emotion, Neurodevelopment and Psychopathology
May 14-16, 2015

Thursday, May 14

12:30-2:30 p.m. Symposium 132: Translational Studies of Motivational Deficits

#TitlePresenters036Mesocorticolimbic Predictors of Responses to Psychotherapy in Major DepressionMoria Smoski, Hannah Carl, Chris Petty

12:30-2:30 p.m. Oral Session 136: Neuromodulation

#TitlePresenters059 Re-evaluating the Electroconvulsive Therapy Stimulus: Frequency and DirectionalityAngel V. Peterchev, Christopher Sikes-Keilp, Moacyr A. Rosa, Sarah H. Lisanby

3:00-5:00 p.m. Symposium 150: New Findings and Future Outlooks from Studies of Biomarkers for Precision Medicine in Affective Disorders (MDD and Mania)

#TitlePresenters083Pre-treatment Brain MRI Measures to Identify Individuals Who Will and Will Not Remit During Acute Phase Treatment With Anti-depressant Medications - Results From the iSPOT-D StudyJohn Rush

3:00-5:00 p.m. Symposium 153: Psychiatric Neuromodulation: Bridging Mechanisms to Therapeutics

#TitlePresenters096Can We Use Brain Oscillations to Guide Treatment of MDD?Andrew D. Krystal, Sarah H. Lisanby

3:00-5:00 p.m. Oral Session 155: Stress, Trauma, Fear

#TitlePresenters103Assessment of Myelin Compromise in Mild Traumatic Brain Injury with Quantitative Susceptibility MappingRajendra A. Morey, Christine E. Marx, Chunlei Liu

3:00-5:00 p.m. Oral Session 267: Psychotic Disorder Treatment

#TitlePresenters518Magnitude and Predictors of MATRICS Consensus Cognitive Battery Change in Placebo Treated Patients with SchizophreniaRichard Keefe522Effects of Glutamate Modulators on Cognitive Impairments In Schizophrenia: A Meta-Analysis of Double-Blind Controlled TrialsRichard Keefe

5:00-7:00 p.m. Poster Session 160

#TitlePresenters173 Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Sleep Disturbances: An Exploratory StudyAndrew Krystal289Ictal EEG Correlates of Neurocognitive Outcome in Electroconvulsive Therapy and Magnetic Seizure TherapyZhi-De Deng, Shawn M. McClintock, Sarah H. Lisanby335Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIsMichael J. Pencina350 Positive Correlation Between Nightmares and Heart Rate Response to Loud Tones Supports Parasympathetic Dysfunction in Posttraumatic Stress DisorderPatricia A. Resick

Friday, May 13

5:00-7:00 Poster Session 270

#TitlePresenters532Autism Pay-per-view: Evidence for Differential Implicit Reward Value of Social and Nonsocial Stimuli in Children with Autism from an Econometric Choice TaskMichael Plat541FRAS1-related Extracellular Matrix 3 (FREM3) Single-nucleotide Polymorphism (rs7676614) Genotype Effects on Amygdala Reactivity and Perceptual Processing SpeedSpenser R. Radtke585Restored WAVE1 Levels in a Model of NMDA Receptor Hypofunction Attenuates Working Memory DeficitsScott H. Soderling620Investigating Polygenic Contributions of Common Hippocampal Variants to Epilepsy PredispositionDavid Goldstein705 Endurance of Neural response to Rewards Predicts Post-Treatment Depression SeverityMoria Smoski, PhD, Jared Minkel, Tyler Moore, Hannah Carl708 Walking Corpse Syndrome Presenting With Catatonia: Case Report and Literature ReviewSayanti Bhattacharya, Jane P. Gagliardi

5:00-7:00 p.m. Late Breaking Poster Session 275

#TitlePresenters770Regulation of BDNF Exocytosis and Gabaergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1Shawn Je

 

Saturday, May 14

3:00-5:00 p.m. Oral Session 355: Translational Approaches Across Disorders

#TitlePresenters909Lifetime Stress Accelerates Epigenetic AgingAnthony S. Zannas

3:00-5:00 p.m. Oral Session 356: Affective Disorders

#TitlePresenters914Aryl Hydrocarbon Receptor (AHR) Genetic Variation is Associated with Baseline Plasma Kynurenine (KYN) Concentrations in Major Depressive Disorder (MDD) Mediated by AHR-Repressor (AHRR): A Pharmacometabolomics-Informed Pharmacogenomic StudyHongjie Zhu, Rima Kaddurah-Daouk

 

International Society for ECT and Neurostimulation 2015 Annual Meeting
May 16-17, 2015

Session 1 TimeSession 2 TimeLocationPresenterWorkshop12:50 p.m.2:40 p.m.
Sarah H. Lisanby, MDTMS Workshop

Mustafa Husain, MD

Novel Brain Stimulation (BDS/tDCS/MST) 

 

Shawn McClintock, PhD, Patient Advisory Committee

Family Centered Care in ECT